Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Infertility 1Anovulation 1

Interventions

Clomiphene 5Letrozole 4follitropin alfa 2Medroxyprogesterone Acetate 2follitropin beta 1drospirenone and ethinyl estradiol combination 1drospirenone 1Urofollitropin 1Thyrotropin 1Testosterone 1Surgical Procedures, Operative 1Sugars 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Oils 1Menotropins 1Luteinizing Hormone 1Leuprolide 1Goserelin 1Glycoprotein Hormones, alpha Subunit 1Flutamide 1Ethinyl Estradiol 1Cyclophosphamide 1Body Mass Index 1Blood Urea Nitrogen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Infertility × Glycoprotein Hormones, alpha Subunit × Clear all
NCT01081626 2014-02-13

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Merck KGaA, Darmstadt, Germany

Phase 4 Completed
310 enrolled 18 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡